CINXE.COM

<!DOCTYPE html> <html xmlns="http://www.w3.org/1999/xhtml"> <head>  <script async src="https://www.googletagmanager.com/gtag/js?id=UA-5483862-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-5483862-1'); </script>  <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-NFW5DS9');</script>  <script> //------------------------------------------------------- var z_account = "2632C1D8-6432-4D3A-93D6-08AAECC53F86"; var z_collector = "asgct.informz.net"; var z_cookieDomain = ".asgct.org"; //------------------------------------------------------- (function (e, o, n, r, t, a, s) { e[t] || (e.GlobalSnowplowNamespace = e.GlobalSnowplowNamespace || [], e.GlobalSnowplowNamespace.push(t), e[t] = function () { (e[t].q = e[t].q || []).push(arguments) }, e[t].q = e[t].q || [], a = o.createElement(n), s = o.getElementsByTagName(n)[0], a.async = 1, a.src = r, s.parentNode.insertBefore(a, s)) }(window, document, "script", "https://"+z_collector+"/web_trk/sp.js", "informz_trk")), informz_trk("newTracker", "infz", z_collector + "/web_trk/collector/", { appId: z_account, cookieDomain: z_cookieDomain }), informz_trk("setUserIdFromLocation", "_zs"), informz_trk("enableActivityTracking", 30, 15); informz_trk("trackPageView", null); </script> <meta charset="utf-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width,user-scalable=no,maximum-scale=1.0,initial-scale=1.0"> <link href="/BlueKey/assets/css/app.css" rel="stylesheet"> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:description" content="" /> <meta name="twitter:title" content="Outstanding New Investigator Awards | ASGCT - American Society of Gene & Cell Therapy" /> <meta name="twitter:site" content="https://twitter.com/ASGCTherapy" /> <meta name="twitter:image" content="https://www.asgct.org/getattachment/072df531-d910-4d3c-a3dc-c02c330a1970/attachment.aspx" /> <meta name="twitter:creator" content="@ASGCTherapy" /> <script type="text/javascript" src="//platform-api.sharethis.com/js/sharethis.js#property=5ae883c34d3f70001197fe0b&product=inline-share-buttons"></script>  <script> (function (h, o, t, j, a, r) { h.hj = h.hj || function () { (h.hj.q = h.hj.q || []).push(arguments) }; h._hjSettings = { hjid: 1655159, hjsv: 6 }; a = o.getElementsByTagName('head')[0]; r = o.createElement('script'); r.async = 1; r.src = t + h._hjSettings.hjid + j + h._hjSettings.hjsv; a.appendChild(r); })(window, document, 'https://static.hotjar.com/c/hotjar-', '.js?sv='); </script> <script type="text/javascript"> adroll_adv_id = "LMOGHWAXC5CQHBCHNDJOMB"; adroll_pix_id = "PLJOCPLDXJHPLKUBZAWMIO"; adroll_version = "2.0"; (function(w, d, e, o, a) { w.__adroll_loaded = true; w.adroll = w.adroll || []; w.adroll.f = [ 'setProperties', 'identify', 'track' ]; var roundtripUrl = "https://s.adroll.com/j/" + adroll_adv_id + "/roundtrip.js"; for (a = 0; a < w.adroll.f.length; a++) { w.adroll[w.adroll.f[a]] = w.adroll[w.adroll.f[a]] || (function(n) { return function() { w.adroll.push([ n, arguments ]) } })(w.adroll.f[a]) } e = d.createElement('script'); o = d.getElementsByTagName('script')[0]; e.async = 1; e.src = roundtripUrl; o.parentNode.insertBefore(e, o); })(window, document); adroll.track("pageView"); </script> <script type="text/javascript" defer="defer" src="https://extend.vimeocdn.com/ga/127349852.js"></script><meta charset="UTF-8" /> <link href="/App_Themes/Default/Images/favicon.ico" type="image/x-icon" rel="shortcut icon"/> <link href="/App_Themes/Default/Images/favicon.ico" type="image/x-icon" rel="icon"/> <title> Outstanding New Investigator Awards | ASGCT - American Society of Gene & Cell Therapy | ASGCT - American Society of Gene & Cell Therapy </title></head> <body class="LTR IE IE7 ENUS ContentBody ASGCTDefaultPage"  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NFW5DS9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>  <form method="post" action="/awards/honorific-awards/outstanding-new-investigator-awards" id="aspnetForm"> <div class="aspNetHidden"> <input type="hidden" name="__CMSCsrfToken" id="__CMSCsrfToken" value="AVSvF3jj5d7noZxHmNRUXgEGDEl6NjHn5ww+KF1rNiPSgFEDo3IxnIjn4/4a0A9g5iz4kag2UB+4Xueah6HBevyADTY=" /> <input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="" /> <input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="" /> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" /> </div> <script type="text/javascript"> //<![CDATA[ var theForm = document.forms['aspnetForm']; if (!theForm) { theForm = document.aspnetForm; } function __doPostBack(eventTarget, eventArgument) { if (!theForm.onsubmit || (theForm.onsubmit() != false)) { theForm.__EVENTTARGET.value = eventTarget; theForm.__EVENTARGUMENT.value = eventArgument; theForm.submit(); } } //]]> </script> <script src="/WebResource.axd?d=UZQNzmZXG1IdUaHxtavOjRvGEvOmz1kvw97PqEaxzBy7Ys-tUotw-RqgdbsvC3g_7cXjehqAdA_N6kbuK73WBAVGdxo1&t=638562384440000000" type="text/javascript"></script> <input type="hidden" name="lng" id="lng" value="en-US" /> <script type="text/javascript"> //<![CDATA[ function PM_Postback(param) { if (window.top.HideScreenLockWarningAndSync) { window.top.HideScreenLockWarningAndSync(1080); } if(window.CMSContentManager) { CMSContentManager.allowSubmit = true; }; __doPostBack('ctl00$CMSPortalManager1$am',param); } function PM_Callback(param, callback, ctx) { if (window.top.HideScreenLockWarningAndSync) { window.top.HideScreenLockWarningAndSync(1080); }if (window.CMSContentManager) { CMSContentManager.storeContentChangedStatus(); };WebForm_DoCallback('ctl00$CMSPortalManager1$am',param,callback,ctx,null,true); } //]]> </script> <script src="/ScriptResource.axd?d=WTJtoz6EJe-loUBJ9stbRxqzgpVp8oo0KdZGkhGfcu6Lr7kb5LeNfx21FKi8mxEL1oDZOLAxiAqERpClgBx-A6lZ0DJ1qKcDZB1NuIbRd8o9S7aG0&t=7c776dc1" type="text/javascript"></script> <script src="/ScriptResource.axd?d=y6KGkkRaceYF_mkApXCXMQ_rMQVX59BlJ-ut-lQDHw88bR5bbS86epdVNwimj01duE6_OophLX4sBTOgb8_5dNLaY2Mx5DHMJj7Rbr4kPMV1-AOS5VF5-QEC8oG-_-aHoWoyqA2&t=7c776dc1" type="text/javascript"></script> <script type="text/javascript"> //<![CDATA[ var CMS = CMS || {}; CMS.Application = { "isDialog": false, "isDebuggingEnabled": false, "applicationUrl": "/", "isRTL": "false", "imagesUrl": "/CMSPages/GetResource.ashx?image=%5bImages.zip%5d%2f" }; //]]> </script> <div class="aspNetHidden"> <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="23D5A2CF" /> <input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEdAATjpK89sYHQVHw6veytztLyWc/UGC0MiqcU6HCwvNVJvgzDekAIswc+CqD21He/aAGQ9TUHX5f3Frmq+VYe3Rj0Td36an35AiC7iGYYVYAI7v7Mrm8=" /> </div> <script type="text/javascript"> //<![CDATA[ Sys.WebForms.PageRequestManager._initialize('ctl00$manScript', 'aspnetForm', ['tctl00$ctxM',''], [], [], 90, 'ctl00'); //]]> </script> <div id="ctl00_ctxM"> </div> <div class="wide"> <header> <div class="container"> <div class="logo"><a href="/"><img src="/BlueKey/assets/images/logo.png" alt="American Society of Gene and Cell Therapy"></a></div> <div class="topSearchWrapper"> <div class="topSearch"> <input type="text" placeholder="Enter Search Text Here"> <input type="submit" value="Go"> </div> <div class="topSearchToggle"></div> </div> <div class="topLinks"> <ul> <li><a href="/contact">Contact Us</a></li> </ul> </div> <div class="socialLinks topSocial"> <ul> <li><a href="https://twitter.com/ASGCTherapy" target="_blank"><i class="bk-icon-twitter"></i></a></li> <li><a href="https://www.facebook.com/asgctherapy" target="_blank"><i class="bk-icon-facebook"></i></a></li> <li><a href="https://www.instagram.com/asgctherapy" target="_blank"><i class="bk-icon-instagram"></i></a></li> <li><a href="https://www.youtube.com/user/ASGCT" target="_blank"><i class="bk-icon-youtube"></i></a></li> <li><a href="https://www.linkedin.com/company/asgct/" target="_blank"><i class="bk-icon-linkedin"></i></a></li> </ul> </div> <div class="topActions"> <input type="submit" name="ctl00$bkSiteHeader$logoutButton$btnSignOut" value="Member Login" id="ctl00_bkSiteHeader_logoutButton_btnSignOut" class="signoutButton btn btn-accent3 ghost btn-default" /> </div> <div class="menuToggle"></div> </div> <div id="ctl00_bkSiteHeader_headerBanner"> <div class="header-alert"> <div class="container"> <p><b><a href="https://annualmeeting.asgct.org/abstracts">Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!</a></b></p> </div> </div> </div> <div class="navShade"></div> <div class="mainNav"> <div class="container"> <ul id="cmsMainNav" class="CMSListMenuUL"> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/annual-meeting">Annual Meeting</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/registration">Register</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/sponsor-exhibit">Sponsor & Exhibit</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/future-annual-meetings">Future Annual Meetings</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/annual-meeting-archives">Annual Meeting Archives</a></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/program">Program</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/program/workshops">Workshops</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/program/schedule-at-a-glance">Venue Maps</a></li></ul></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/abstracts">Abstracts</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/abstracts/present">Present</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/abstracts/awards">Awards</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/abstracts/topics">Topics</a></li></ul></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/membership">Membership</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/video-library">Video Library</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/annual-meeting">Annual Meeting</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/cancer">Cancer</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/career-skills">Career Skills</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/gene-editing">Gene Editing</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/patients-and-clinicians">Patients and Clinicians</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/regulatory">Regulatory</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/aav">Viral Vectors</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/become-a-member">Become a Member</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/economy-based-rates">Economy-Based Rates</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/grants-awards">Awards</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/membership-directory-new">Membership Directory</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/scientific-committees">Scientific Committees</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/standing-committees">Standing Committees</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/my-profile">My Profile</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href=" http://jobs.asgct.org/" target="_blank">Career Center</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/submit-an-abstract">ASGCT Abstracts</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/submit-an-abstract/asgct-abstract-submission-windows">Abstract Submission Windows</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/volunteer">Volunteer</a></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/events">Events</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/around-the-world-advanced-therapy-medicinal-produc">Around the World: Advanced Therapy Medicinal Production in South America</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/molecular-therapy-presents-extracellular-vesicles">Molecular Therapy Presents: Extracellular Vesicles</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/empowering-patients-2025-a-cell-and-gene-therapies">Empowering Patients 2025: A Cell and Gene Therapies Summit</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/non-asgct-events">Non-ASGCT Events</a></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/breakthroughs-in-muscular-dystrophy">Breakthroughs in Muscular Dystrophy</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/registration">Registration</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/abstracts">Abstracts</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/program">Program</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/speaker-and-attendee-resources">Speaker + Attendee Resources</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/sponsorship">Sponsorship</a></li></ul></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/class-considerations-on-immunogenicity-for-aav-gen">Class Considerations on Immunogenicity for AAV GT Products: Assessing Current Practice + New Data</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/career-development-seminars">Professional Development Caf茅s</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/career-development-seminars/focused-ultrasound-cutting-edge-applications-in-ce">Dec. 13: Focused Ultrasound: Cutting-Edge Applications in Cell and Gene Therapies</a></li></ul></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/awards">Awards</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/honorific-awards">Honorific Awards</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/outstanding-achievement-award">Outstanding Achievement Award</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/outstanding-new-investigator-awards">Outstanding New Investigator Awards</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/george-stamatoyannopoulos-mentorship-award">George Stamatoyannopoulos Mentorship Award</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/excellence-advancing-diversity-equity-inclusion">Award for Excellence in Advancing Diversity, Equity, and Inclusion</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/exemplary-service-award">Exemplary Service Award</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/career-development-awards">Career Development Awards</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/congressional-policy-fellowship">Congressional Policy Fellowship</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/underrepresented-populations-fellowship">Underrepresented Populations in Gene and Cell Therapy</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/mavis-agbandje-mckenna-scholarship-and-fund">Mavis Agbandje-McKenna Scholarship and Fund</a></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/education">Outreach</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/clinicaltrials">Clinical Trials Finder</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/lunch-learn-events">Community Quick Takes</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/lunch-learn-events/informed-consent">Informed Consent</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/lunch-learn-events/state-of-the-field-highlights-approvals-for-cgt">State of the Field Highlights + Approvals for CGT in 2023</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/lunch-learn-events/access-to-approved-cell-and-gene-therapies">Access to Approved Cell and Gene Therapies</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/lunch-learn-events/genetic-testing-and-clinical-trial-eligibility">Genetic Testing and Clinical Trial Eligibility</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/diversity-equity-and-inclusion-mission-goals">Diversity, Equity, and Inclusion</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/diversity-equity-and-inclusion-mission-goals/biotech-discovery-labs-program">Biotech Discovery Labs Program</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/gene-therapy-101">Patient Education: Gene Therapy 101</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/gene-therapy-basics">Gene Therapy Basics</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/gene-therapy-approaches">Gene Therapy Approaches</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/developing-a-treatment">Clinical Trials Process</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/vectors-101">Vectors 101</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/gene-editing">Gene Editing</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/global-outreach">Global Outreach</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/disease-treatments">Patient Education: Condition Treatments</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/beta-thalassemia-other-blood-disorders">Beta Thalassemia & Other Blood Disorders</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/leukodystrophy">CALD and MLD</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/spinal-muscular-atrophy">Spinal Muscular Atrophy</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/blood-cancers-car-t-cell-therapy">CAR-T Basics</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/hemophilia-gene-therapy">Hemophilia</a></li></ul></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/publications">Publications</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/news">ASGCT Blog</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/the-patient-press">The Patient Press</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/the-patient-press/october-2024">October 2024</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/the-vector">The Vector</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/landscape-report">Quarterly Gene, Cell, and RNA Therapy Landscape Report</a></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/asgct-podcast-network">ASGCT Podcast Network</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/asgct-podcast-network/giants-of-gene-therapy">Giants of Gene Therapy</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/asgct-podcast-network/the-issue">The Issue</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/asgct-podcast-network/the-molecular-therapy-podcast">The Molecular Therapy Podcast</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/the-advocate">The Advocate</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/the-advocate/subscribe-to-the-advocate">Subscribe to The Advocate</a></li></ul></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/molecular-therapy">Molecular Therapy Family</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/molecular-therapy-presents-targets-and-biomarkers">Molecular Therapy Presents Extracellular Vesicles</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/cell-press-webinar-advances-in-viral-vector-gene-d">Cell Press Webinar: Advances in Viral Vector Gene Delivery for CT Biomanufacturing</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/molecular-therapy">Molecular Therapy</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/mt鈥搈ethods-clinical-development">MT Methods & Clinical Development</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/mt鈥搉ucleic-acids">MT Nucleic Acids</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/mt鈥搊ncolytics">MT Oncology</a></li></ul></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/advocacy">Advocacy</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/advocacy/events-and-opportunities">Events and Opportunities</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/policy-summit">Policy Summit</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/asgct-fda-liaison-meeting-(1)">ASGCT-FDA Liaison Meeting</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/cgt-science-series">Cell + Gene Therapy Science Series</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/congressional-policy-fellowship">Congressional Policy Fellowship</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/fda-immune-responses-aav-vectors">FDA & ASGCT: Immune Responses to AAV Vectors</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/advocacy/policy-priorities">Policy Priorities</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/policy-priorities/patient-access-overview">Patient Access Overview</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/policy-priorities/regulatory-policy">Regulatory Policy</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/policy-priorities/research-funding">Research Funding</a></li></ul></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/advocacy/the-advocate">The Advocate</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/the-advocate/subscribe-to-the-advocate">Subscribe to The Advocate</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/advocacy/policy-statements-letters">Policy Statements & Letters</a></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/about">About</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/leadership">Leadership</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/leadership/board-officers">Board of Directors</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/leadership/scientific-committees">Scientific Committees</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/leadership/standing-committees">Standing Committees</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/leadership/staff">Staff</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/careers">Work at ASGCT</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/careers/development-coordinator">Development Coordinator</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/careers/education-coordinator">Education Coordinator</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/careers/meeting-planner">Meeting Planner</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/media">Media</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/culture">Our Culture</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/strategic-plan">Strategic Plan</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/meeting-code-of-conduct">Meeting Code of Conduct</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/terms-and-conditions">Terms and Conditions</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/mission-vision">Mission & Vision</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/mission-vision/bylaws">Bylaws</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/support">Support ASGCT</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/annual-meeting-support">Annual Meeting Support</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/advertise-asgct-publications">Advertise in ASGCT Publications</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/support-asgct-s-digital-programs">Digital Programs</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/giving">Giving</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/year-round-support">Year-Round Support</a></li></ul></li></ul> </div> </li> </ul> </div> <div class="mainNavClose"></div> </div> </header> <div class="masthead" style="background: url('/getattachment/Awards/Honorific-Awards/Outstanding-New-Investigator-Awards/mtcover_image1206.png.aspx') 50% 50% no-repeat; background-size: cover;"> <div class="container"></div> </div> <section class="mainBody"> <div class="container"> <main> <h1>Outstanding New Investigator Awards</h1> <h2></h2> <hr /> <h2>About the Award</h2> <p>Several Outstanding New Investigators are recognized each year based on their contributions to the field of gene and cell therapy. Investigators from academia, research foundations, government, and industry are all eligible to be nominated for awards. Recipients of the Outstanding New Investigator Awards are celebrated at the <a href="https://annualmeeting.asgct.org/" target="_blank">ASGCT Annual Meeting</a> every year. Each awardee will present a plenary lecture highlighting their scientific accomplishments that led to the award.</p> <h2>Criteria and Nominations</h2> <p>Any ASGCT member, other than a current officer or member of the Nomination and Awards Committee, is eligible. Nomination letters must be 500 words or fewer and be submitted by two ASGCT members. Nominees will be notified and required to provide a CV or NIH bio-sketch.</p> <p>To be eligible, nominees must be:</p> <ol> <li> <p>Independent investigators conducting original research in basic science, technology development, and/or clinical translation in the field of gene and cell therapy;</p> </li> <li> <p>Ten or fewer years out from their first active independent investigator position;</p> </li> <li> <p>Members in good standing of the Society;</p> </li> <li> <p>Nominated by two (or more) ASGCT members in good standing; and </p> </li> <li> <p>Available to give a presentation of their work at the next ASGCT Annual Meeting.</p> </li> </ol> <p>Nominate yourself or a colleague through <strong>September 16</strong>! Send nominations letters to <a href="mailto:awards@asgct.org">awards@asgct.org</a>.</p> <h2>Recipients</h2> <p><strong>2024</strong></p> <p>Agnieszka Czechowicz, MD, PhD, Stanford University<br /> Pietro Genovese, PhD, Dana-Farber Cancer Institute + Harvard Medical School<br /> Jennifer Hamilton, PhD, Innovative Genomics Institute (IGI)<br /> Sharif Tabebordbar, PhD, Kate Therapeutics</p> <p><strong>2023</strong></p> <p>Maksim “Max” Mamonkin, PhD, Baylor College of Medicine + March Bio<br /> Justin Eyquem, PhD, University of California, San Francisco + Mnemo Therapeutics<br /> Shondra Pruett-Miller, PhD, St. Jude Children’s Research Hospital<br /> Manuela Corti, PhD, University of Florida</p> <p><strong>2022</strong></p> <p>Lindsey George, MD, Childen's Hospital of Philadelphia<br /> Matthew Hirsch, PhD, University of North Carolina<br /> Morgan Maeder, PhD, Chroma Medicine<br /> Christopher Peterson, PhD, Fred Hutchinson Cancer Center</p> <p><strong>2021</strong></p> <p>Natalia Gomez-Ospina, MD, PhD, Stanford University<br /> Benjamin Kleinstiver, PhD, Massachusetts General Hospital<br /> Marcela Maus, MD, PhD, Massachusetts General Hospital<br /> Annarita Miccio, PhD, Imagine Institute</p> <p><strong>2020</strong><br /> Daniel Bauer, M.D., Ph.D., Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School<br /> Gene Editing for Autologous Hematopoietic Stem Cell Therapy<br /> <br /> James Dahlman, Ph.D., Georgia Tech and Emory University<br /> Identifying LNPs with Novel Tropism by Testing Thousands in Vivo Using DNA Barcodes<br /> <br /> Viviana Gradinaru, Ph.D., California Institute of Technology (Caltech)<br /> Systemic Gene Delivery to the Central and Peripheral Nervous Systems and Applications to Neurodegeneration<br /> <br /> Shengdar Tsai, Ph.D., St. Jude Children's Research Hospital<br /> Understanding and Improving Genome Editors for Therapeutics</p> <p><strong>2019</strong><br /> Steven J. Gray, Ph.D., University of Texas Southwestern Medical Center, Dallas TX<br /> On the Brink of a Treatment Revolution for Inherited Pediatric Neurological Diseases</p> <p>Anna Kajaste-Rudnitski, Ph.D., San Raffaele Telethon Institute for Gene Therapy, Milano Italy<br /> Dissecting and Overcoming Innate Immune Barriers for Therapeutically Efficient Hematopoietic Stem Cell Gene Engineering</p> <p><strong>2018</strong><br /> Luca Biasco, Ph.D., Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston MA<br /> Clonal Tracking of Genetically Engineered Hematopoietic Cells in Humans</p> <p>Luk Vandenberghe, Ph.D., Grousbeck Gene Therapy Center, Boston, MA<br /> On the Shoulders of Giants: Building Vectors and Gene Therapies</p> <p><strong>2017</strong><br /> James Kochenderfer, M.D., National Cancer Institute<br /> Chimeric Antigen Receptor T-cell Therapies for Hematologic Malignancies</p> <p>Lili Yang. Ph.D., University of California Los Angeles<br /> Stem Cell-Engineered T Cell Immunotherapy for Cancer</p> <p><strong>2016</strong><br /> Jordan Green, Ph.D., Johns Hopkins University<br /> Polymeric Nanoparticles for Gene and Cell Therapy to Treat Cancer</p> <p>Marcin Kortylewski, Ph.D. - City of Hope Comprehensive Cancer Center<br /> Eliminating Tumor Immune Defenses using Oligonucleotide Therapeutics</p> <p>Eirini P. Papapetrou, M.D., Ph.D. - Icahn School of Medicine at Mount Sinai<br /> Genetic Engineering of Human Induced Pluripotent Stem Cells for Regenerative Medicine and Disease Modeling</p> <p>Junghae Suh, Ph.D. - Rice University<br /> Design of Biocomputing Viruses for Controlled Gene Delivery</p> <p><strong>2015</strong><br /> Jennifer E. Adair, Ph.D., Fred Hutchinson Cancer Research Center<br /> Found in Translation: Informed Development of Next-Generation Blood Stem Cell Gene Therapy</p> <p>Ana Buj Bello, M.D., Ph.D., Genethon<br /> Towards a Gene Therapy for Myotubular Myopathy</p> <p>Dirk Grimm, Ph.D., University of Heidelberg<br /> Small Viruses + Tiny RNAs = A Giant Toolbox for Gene and Cell Therapy</p> <p>Eugenio Montini, Ph.D., San Raffaele Telethon Institute for Gene Therapy<br /> Genetic Engineering of Somatic Cells by Viral/Vector Integrations in Gene Therapy and HIV-1 Infection</p> <p><strong>2014</strong><br /> Brian D. Brown, Ph.D., Mt. Sinai School of Medicine<br /> Dangerous Liaisons: Gene Transfer, microRNA, and the Immune System</p> <p>Charles A. Gersbach, Ph.D., Duke University<br /> Targeted Gene Correction and Regulation with Genome Engineering Technologies</p> <p>Scott Q. Harper, Ph.D., Ohio State University & Nationwide Children's Hospital<br /> Translating Facioscapulohumeral Muscular Dystrophy (FSHD)</p> <p>Daniel J. Powell, Jr., Ph.D., University of Pennsylvania<br /> Innovative Approaches to Adoptive T cell Therapy of Cancer</p> <p><strong>2013</strong><br /> Aravind Asokan, Ph.D., University of North Carolina at Chapel Hill<br /> A Sweet Side to AAV Biology</p> <p>Paloma H. Giangrande, Ph.D., University of Iowa<br /> Targeted-Image Guided RNA (TIGR) Therapies</p> <p>Michael A. Laflamme, M.D., Ph.D., University of Washington<br /> Cardiac Repair with Human Pluripotent Stem Cells</p> <p>Ann M. Leen, Ph.D., Baylor College of Medicine - CAGT<br /> T cell Therapy for Viruses and Cancer</p> <p><strong>2012</strong><br /> Nicola Brunetti-Pierri,M.D., Telethon Institute of Genetics and Medicine, Napoli, Italy<br /> Helper-Dependent Adenoviral Vectors for Hepatocyte Gene Therapy</p> <p>Marco A. Passini, Ph.D., Genzyme - A Sanofi Company, Framingham, MA<br /> Gene and Antisense Therapies for Neurodegenerative Disorders</p> <p>Theresa M. Reineke, Ph.D., University of Minnesota<br /> Design and Discovery of Glycopolymer Vehicles for the Delivery of Nucleic Acids</p> <p>Benjamin R. tenOever, Ph.D., Mount Sinai School of Medicine<br /> Harnessing the Power of Small RNAs in Vector-Mediated Therapeutics</p> <p><strong>2011</strong><br /> Hiroyuki Nakai, M.D., Ph.D., University of Pittsburgh School of Medicine, Pittsburgh, PA<br /> In Vivo Viral Genome and Capsid Biology of Recombinant AAV Vectors</p> <p>Miguel Sena-Esteves, Ph.D., University of Massachusetts Medical School, Worcester, MA<br /> AAV-Mediated Gene Therapy for Neuro-Metabolic Diseases and Brain Tumors</p> <p>Qizhen Shi, M.D., Ph.D., Medical College of Wisconsin, Milwaukee, WI<br /> Targeting Factor VIII (FVIII) Expression to Platelets for Gene Therapy of Hemophilia A with Inhibitors</p> <p><strong>2010</strong><br /> Alessandra Biffi, M.D., San Raffaele Telethon Institute for Gene Therapy, Milan, Italy<br /> Rendering Hematopoietic Stem Cell Transplantation Efficacious for the Treatment of Lysosomal Disorders</p> <p>Kevin V. Morris, Ph.D., Scripps Research Institute, La Jolla, CA<br /> Utilizing the Endogenous Long Non-Coding RNA Pathway in Human Cells to Transcriptionally Modulate Gene Expression</p> <p>Bakhos A. Tannous, Ph.D., Massachusetts General Hospital, Charlestown, MA<br /> Ex-Vivo Monitoring of In Vivo Gene and Cell Therapy</p> <p>Charles P. Venditti, M.D., Ph.D., National Human Genome Research Institute, Bethesda, MD<br /> Gene Therapy for Methylmalonic Acidemia (MMA)</p> <p><strong>2009</strong><br /> Renier J. Brentjens, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center, New York, NY<br /> Treatment of B-cell Malignancies with CD19 Targeted T-cells</p> <p>Barbara Savoldo, M.D., Ph.D., Baylor College of Medicine, Houston, TX<br /> Improving T Cell Based Therapies</p> <p>Tatiana Segura, Ph.D., University of California-Los Angeles, Los Angeles, CA<br /> Gene Delivery In Three Dimensions</p> <p><strong>2008</strong><br /> Karen S. Aboody, M.D., City of Hope National Medical Center, Duarte CA<br /> Stem Cell-Mediated Cancer Therapy: A Tumor-Selective Gene Delivery Approach</p> <p>Maciej S. Lesniak, M.D., FACS, The University of Chicago, Chicago, IL<br /> Adenoviral Virotherapy for Malignant Brain Tumors</p> <p>Dmitry M. Shayakhmetov, Ph.D., University of Washington, Seattle, WA<br /> Adenovirus-Host Interplay and the Development of Efficient Vectors for Gene Therapy</p> <p><strong>2007</strong><br /> Gianpietro Dotti, M.D., Baylor College of Medicine, Houston, TX<br /> Genetic Modifications of T Cells for Adoptive Immunotherapy in Cancer Patients</p> <p>Akseli E. Hemminki, M.D., Ph.D., University of Helsinki, Helsinki, Finland<br /> Oncolytic Adenoviruses for Killing of Cancer Initiating Cells</p> <p>Philip Ng, Ph.D., Baylor College of Medicine, Houston, TX<br /> Gene Therapy with Helper-Dependant Adenoviral Vectors</p> <p>Derek Persons, M.D., Ph.D., St. Jude Children’s Research Hospital, Memphis, TN<br /> Progress Toward Safe and Effective Gene Therapy for β-Thalassemia and Sickle Cell Disease</p> <p><strong>2006</strong><br /> Alberto Auricchio, M.D., Telethon Institute of Genetics & Medicine, Napoli, Italy<br /> AAV Serotypes for Gene Therapy of Inherited Human Diseases</p> <p>Dongsheng Duan, Ph.D., University of Missouri School of Medicine, Columbia, MO<br /> Pushing the Limit: Making a Small Virus to Work for a Large Gene</p> <p>Salima Hacein-Bey Abina, Ph.D., INSERM U 429, Paris, France<br /> Gene Therapy for Severe Combined Immunodeficiency X1</p> <p>Punam Malik, M.D., Children’s Hospital Los Angeles, Los Angeles, CA<br /> Gene Therapy for Red Blood Cell Disorders</p> <p><strong>2005</strong><br /> Chiara Bonini, M.D., Fondazione Centro S. Raffaele Del Monte Tabor, Milan, Italy<br /> Gene Transfer into Peripheral Blood T Lymphocytes: Clinical Benefits and Safety Profile</p> <p>Michael Kaplitt, M.D., Ph.D., Weill Medical College of Cornell University, New York, NY<br /> Development of Human Gene Therapy for Neurodegenerative Disorders</p> <p><strong>2004</strong><br /> Michael A. Barry, Ph.D., Baylor College of Medicine, Houston, TX<br /> Cell-Targeting Technologies for Gene Therapy</p> <p>Laurence JN Cooper, M.D., Ph.D., City of Hope National Medical Center, Duarte, CA<br /> T-cell Therapy for Malignant B Cells</p> <p>Matthew Weitzman, Ph.D., Salk Institute, La Jolla, CA<br /> Lessons from the Battleground of Virus-Host Interactions</p> <p><strong>2003</strong><br /> Alessandro Aiuti, M.D., Ph.D., Fondazione Centro San Raffaele, Milan, Italy<br /> Gene Therapy for ADA-Deficient SCID</p> <p>Roland W. Herzog, Ph.D., Children’s Hospital of Philadelphia, Philadelphia, PA<br /> Immunology of Factor IX Gene Transfer</p> <p>Christof von Kalle, M.D., Cincinnati Children’s Hospital, Cincinnati, OH<br /> Vector Insertion in Gene Modified Human Hematopoiesis<br />  </p> </main> <aside> <div class="asideBox"> <h4>Related Pages</h4> <ul> <li><a href="/awards/honorific-awards/outstanding-achievement-award">Outstanding Achievement Award</a> </li> <li class="active"><a href="/awards/honorific-awards/outstanding-new-investigator-awards">Outstanding New Investigator Awards</a> </li class="active"> <li><a href="/awards/honorific-awards/george-stamatoyannopoulos-mentorship-award">George Stamatoyannopoulos Mentorship Award</a> </li> <li><a href="/awards/honorific-awards/sonia-skarlatos-public-service-award">Sonia Skarlatos Public Service Award</a> </li> <li><a href="/awards/honorific-awards/founders-award">Founders Award</a> </li> <li><a href="/awards/honorific-awards/excellence-advancing-diversity-equity-inclusion">Award for Excellence in Advancing Diversity, Equity, and Inclusion</a> </li> <li><a href="/awards/honorific-awards/exemplary-service-award">Exemplary Service Award</a> </li> <li><a href="/awards/honorific-awards/jerry-mendell-award-for-translational-science">Jerry Mendell Award for Translational Science</a> </li> <li><a href="/awards/honorific-awards/catalyst-award">Catalyst Award</a> </li> <li><a href="/awards/honorific-awards/best-of-molecular-therapy-award">Best of Molecular Therapy Award</a> </li> </ul> </div> </aside> </div> </section> <div class="event-row"> <div class="year">2025</div> <div class="content"> <h2>Class Considerations on Immunogenicity for AAV GT Products</h2> <p>January 22-23, 2025 | Virtual</p> </div> <div class="action"><a class="btn btn-white" href="https://www.asgct.org/asgct-events/january-2025/class-considerations-on-immunogenicity-for-aav-gen">Learn More</a></div> </div> <footer> <div class="container"> <div class="footerColContainer"> <div class="footerCol"> <p><img alt="logo-footer.png" class="footerLogo" src="/getmedia/c77b7df1-12a2-4998-9809-0a880c107341/ASGCT_Web_Horz_White.aspx" title="logo-footer.png" /></p> <p>20800 Swenson Dr.<br /> Suite 300<br /> Waukesha, WI 53186</p> </div> <div class="footerCol"> <ul> <li><a href="/about">About</a></li> <li><a href="/membership">Membership</a></li> <li><a href="https://annualmeeting.asgct.org" target="_blank">Annual Meeting</a></li> <li><a href="http://www.cell.com/molecular-therapy-family/home" target="_blank">Journal</a></li> </ul> </div> <div class="footerCol"> <ul> <li><a href="/education">Education</a></li> <li><a href="/advocacy">Advocacy</a></li> <li><a href="https://asgct.org/awards" target="_blank">Awards</a></li> <li><a href="https://asgct.org/about/privacy-policy" target="_blank">Privacy Policy</a></li> </ul> </div> <div class="footerCol"> <p class="altStyle">Connect with ASGCT</p> <p><strong>Phone:</strong> 414.278.1341<br /> <a href="mailto:info@asgct.org">info@asgct.org</a><div class="footerSocial"><div id="ctl00_bkSiteFooter_rptFooterBlocks_ctl04_widget1_ctl00_divSocialLinks" class="socialLinks footerSocial"> <ul> <li><a href="https://twitter.com/ASGCTherapy" target="_blank"><i class="bk-icon-twitter"></i></a></li> <li><a href="https://www.facebook.com/asgctherapy" target="_blank"><i class="bk-icon-facebook"></i></a></li> <li><a href="https://www.instagram.com/asgctherapy" target="_blank"><i class="bk-icon-instagram"></i></a></li> <li><a href="https://www.youtube.com/user/ASGCT" target="_blank"><i class="bk-icon-youtube"></i></a></li> <li><a href="https://www.linkedin.com/company/asgct/" target="_blank"><i class="bk-icon-linkedin"></i></a></li> </ul> </div></div></p> </div> </div> </div> </footer> <div class="postFooter"> <div class="container"> <p>© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy. </p> <p class="bkCredit"><a href="https://www.reasononeinc.com/kentico" title="BlueKey is a Full Service Digital Agency and Kentico Gold Partner. Click to learn more about our Kentico development services" target="_blank">Kentico CMS Development by Reason One</a> | <a href="http://www.kentico.com" target="_blank">Powered by Kentico</a></p> </div> </div> <div class="CookieConsent"> <span id="ctl00_cookieLawQ_lblText" class="ConsentText">This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.</span> <span class="ConsentButtons"> <input type="submit" name="ctl00$cookieLawQ$btnAllowSpecific" value="OPT OUT" id="ctl00_cookieLawQ_btnAllowSpecific" class="ConsentButton btn btn-default" /> <input type="submit" name="ctl00$cookieLawQ$btnAllowAll" value="ACCEPT" id="ctl00_cookieLawQ_btnAllowAll" class="ConsentButton btn btn-default" /> </span> </div> <script src="/BlueKey/assets/js/app-dist.js"></script> <script src="/BlueKey/assets/js/timeline-dist.js"></script> </div> <script type="text/javascript"> //<![CDATA[ var callBackFrameUrl='/WebResource.axd?d=nNME_ObE2oIDm535eYM9xWmIMy-HXBVdo54Ly6sA5tAYPS1aA-gFDzodlP9ijTBRgmjStONrH4-ISuRTp7slHiYkACw1&t=638562384440000000'; WebForm_InitCallback();//]]> </script> </form> </body> </html>